FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Marksans Pharma Time-Cap Labs Recall

Time-Cap Labs, Inc

Marksans Pharma Limited · Vasco Da Gama, N/A

Risk level
Class II
Reported by FDA
Jul 1, 2020
Recall ID
D-1356-2020
Check your lot numberHow we source this data

Summary

Marksans Pharma recalled Time-Cap Labs starting Jun 5, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1356-2020 on Jul 1, 2020. Reason: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level. Status: Terminated.

Why it was recalled

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Product description

Time-Cap Labs, Inc. Metformin Hydrochloride Extended-Release Tablets, USP 500 mg Rx Only 100 Tablets bottles, Manufactured for: Time-Cap Labs, Inc. 7 Michael Avenue Farmingdale, NY 11735, USA Manufactured by: Marksans Pharma Ltd. Plot No, L-82, L-83, Verna Intl. Estate, Verna, Goa-403 722, India NDC 49483-623-01

Lot numbers, UPCs & expiration codes

XP9004, exp 12/2020

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1356-2020
Classification
Class II
Status
Terminated
Recall initiated
Jun 5, 2020
FDA report date
Jul 1, 2020
Quantity
11279 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Marksans Pharma Limited

Original FDA data

Every field from FDA enforcement report D-1356-2020, exactly as published.

Show all FDA fields
City
Vasco Da Gama
Status
Terminated
Country
India
Event ID
85818
Address
& L - 83 Plots L - 82
Address (line 2)
Verna, Goa
Code information
XP9004, exp 12/2020
Report date
Jul 1, 2020
Product type
Drugs
Recall number
D-1356-2020
Classification
Class II
Recalling firm
Marksans Pharma Limited
Product quantity
11279 bottles
Termination date
Sep 7, 2023
Reason for recall
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level
Voluntary / mandated
Voluntary: Firm initiated
Product description
Time-Cap Labs, Inc. Metformin Hydrochloride Extended-Release Tablets, USP 500 mg Rx Only 100 Tablets bottles, Manufactured for: Time-Cap Labs, Inc. 7 Michael Avenue Farmingdale, NY 11735, USA Manufactured by: Marksans Pharma Ltd. Plot No, L-82, L-83, Verna Intl. Estate, Verna, Goa-403 722, India NDC 49483-623-01
Distribution pattern
Nationwide
Recall initiation date
Jun 5, 2020
Initial firm notification
Press Release
Center classification date
Jun 25, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1356-2020, published Jul 1, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls